In this 3-part podcast series, the International Federation on Ageing (IFA) aims to raise awareness of hMPV. The series will feature scientists, clinicians and the voices of older people and groups representing those most at risk of serious disease.

The technology provides a universal solution to respiratory viruses, regardless of an individual's immune history – for example, people who do not sufficiently respond to a vaccine, or don't get vaccinated

The European Commission's Health Emergency Preparedness & Response Authority brought together industry stakeholders, innovators and policymakers in Brussels to advance medical countermeasure and innovation, and enhance collaboration in health preparedness

This group will lead the development of a Call to Action to advocate for better access to treatments, in particular COVID- 19.

The initiative consist of key actions, that will amongst others, speed-up vaccine development to less than four months from identifying a pathogen's genomic sequence.

Agreement’s adoption follows three years of intensive negotiation launched due to gaps and inequities identified in national and global COVID-19 response.

Due to its climatic variability, complex mobility networks and geographic expanse, the United States represents a compelling setting to explore the transmission processes that lead to heterogeneous yearly seasonal influenza epidemics.

Celebrated the XIX European Patients’ Rights Day at the EU Parliament

Human infections with swIAV have been detected sporadically in Europe whereas in the United States, such infections have been detected more frequently.

Several viruses that cause problems for human beings originated in bats. However, cellular and tissue models for understanding virus infection in these important reservoir species are limited.

Mandatory housing measures introduced across a large swathe of England to try and curb the spread of avian influenza are being lifted from today (15 May).

The 2025 edition provides the most comprehensive and up-to-date analysis of the nursing workforce.

Several mucosal vaccines are in development, and consistent methodologies assessing mucosal IgA are crucial for evaluation across clinical trials.

Over the past 25 years, there has been an increasing number of mammalian (including human) infections caused by avian influenza A viruses that resulted in mild to severe illnesses.

Novel influenza-like virus sequences previously identified in fish and amphibians were found to cluster as a sister clade of influenza B viruses, but have thus far remained uncharacterized.

2024 saw a novel outbreak of H5N1 avian influenza in US dairy cattle. Limited surveillance data has made determining the true scale of the epidemic difficult.

In 2024, IAV H5N1 highly pathogenic avian influenza (HPAI) in the United States moved into cattle. While the outbreak is currently of low risk to the public, there is an urgent need to monitor the disease and prevent spread.

Frequency, phenotype and T-cell receptor (TCR) composition of influenza-specific CD8+ T-cells directed at the prominent A2/M158 influenza epitope change across the human lifespan.

In an attempt to transform Europe into a stronger global research hub, the European Union and France have unveiled plans to launch a multi-million-euro initiative aimed at making the EU a "magnet" for top international scientists: "Science has no passport

This strategy aims for 95% of individuals infected with HIV to know their status, 95% of those infected to be under effective treatment, and 95% of those receiving treatment to achieve viral suppression.

The recent emergence of highly pathogenic H5N1 avian influenza virus infections in dairy cows and humans in the U.S. has raised alarms regarding the potential for a pandemic.

The pursuit of rigorous medical science is not compatible with capitulation to government demands aimed at weaponising and eroding science.

Highly pathogenic avian influenza (HPAI) viruses cross species barriers and have the potential to cause pandemics.

High-pathogenicity avian influenza subtype H5N1 is now present throughout the US, and possibly beyond.